![]() Sareum Holdings Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. | ![]() Lead Pharma Lead Pharma is a company that discovers, develops, and commercializes therapeutics against cancer and autoimmune diseases. | Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | ![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ||
Founding Date | Founding Date 2003 | Founding Date 2007 | Founding Date 2012 | Founding Date 2015 | Founding Date 2001 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Pampisford, GB HQ | Locations Oss, NL HQ Oss, NL | Locations Houston, US HQ | Locations South San Francisco, US HQ | Locations Lund, SE HQ |
Employees | Employees 5 | Employees 363% decrease | Employees 4426% increase | Employees 64 | Employees 1555% decrease |
Valuation ($) | Valuation ($) 38.1 m | Valuation ($) N/A | Valuation ($) 1.8 m | Valuation ($) 69.8 m | Valuation ($) 59 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit kr1.1m (FY, 2025) |
Net income | Net income (£4.4m) (FY, 2025) | Net income N/A | Net income ($26.9m) (FY, 2024) | Net income ($129.9m) (FY, 2024) | Net income (kr51.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 135k | Total funding raised $ 176m | Total funding raised N/A |

Lead Pharma is a company that discovers, develops, and commercializes therapeutics against cancer and autoimmune diseases.
View companyKiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View company